Enabling More Predictable
Site Execution
Site networks are central to clinical delivery, yet rising protocol complexity, coordinator workload, and enrollment volatility create execution strain. Visibility alone does not ensure predictable performance.
.jpg)
Agentic AI Offerings
Maxis AI delivers supervised intelligent execution across biometrics workflows
Who This is Built for
Site Network CEOs
Improve study acquisition and performance reliability
Directors of Site Operations
Reduce deviations and coordinator overload
VP Clinical Operations
Stabilize enrollment outcomes and multi-site execution consistency.
.jpg)
Where Site Performance Often Slows
%201.svg){kind=icon}
Coordinator workload across multiple active studies
Manual screening that misses eligible patients
Protocol deviations identified during monitoring visits
Site selection based on historical assumptions
Underperforming sites recognized only after enrollment lags
Forecast variability as real-world conditions evolve
How Execution Becomes More Controlled
Continuous patient matching to speed screening
Real-time deviation risk alerts
Live enrollment tracking with early drift detection
Automated triggers for faster intervention
AI-supported workflows with coordinator oversight
Earlier response enabling proactive execution
All You Need to Know
By continuously matching patients to eligibility criteria and identifying at-risk sites earlier for intervention.
Continuous supervised execution and early performance visibility instead of retrospective reporting.
No. It reduces administrative burden while preserving expert oversight.
Yes. Real-time monitoring enables earlier detection and structured response.
Site networks and clinical leaders seeking predictable enrollment and operational consistency.
Looking for Agentic AI for clinical trials?
Explore our Agentic AI Platform to see how AI agents are transforming study startup, data management, oversight, and regulatory submissions.